We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Novel fusion confers ATRA resistance in atypical acute promyelocytic leukemia, indicating a new challenge for treatment.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: